Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Emanuel

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Oncotarget|December 13, 2017
Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjectsLaura F Hutchins, Issam Makhoul, Peter D Emanuel, et al.
Blood Neoplasia|December 22, 2025
Juvenile myelomonocytic leukemia stem cells are sensitive to NK cell-mediated lysis and express targetable antigensShannalee Martinez, Vladimir V Senyukov, Suheyla Hasgur, et al.
Blood|November 15, 1989
Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemiaR J Gualtieri, P D Emanuel, K S Zuckerman, et al.
Blood|December 3, 1998
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemiaA E Frankel, M Lilly, R Kreitman, et al.
Bone Marrow Transplantation|September 1, 1996
Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive diseaseF O Smith, M S Johnson, L R Scherer, et al.
Blood|January 15, 2016
Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancyY Lucy Liu, Yan Yan, Cody Webster, et al.
Experimental Cell Research|July 25, 2003
Inhibition of tumorigenicity by the 5'-untranslated RNA of the human c-myc P0 transcriptScott W Blume, Donald M Miller, Vincenzo Guarcello, et al.
Journal of the American Academy of Dermatology|June 18, 2013
A case of proteasome-associated auto-inflammatory syndrome with compound heterozygous mutationsAmelia McDermott, Adriana Almeida Jesus, Yin Liu, et al.
Journal of Medicinal Chemistry|May 30, 1998
Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemiasD D Muccio, W J Brouillette, T R Breitman, et al.
American Journal of Human Genetics|December 17, 2005
Diversity and functional consequences of germline and somatic PTPN11 mutations in human diseaseMarco Tartaglia, Simone Martinelli, Lorenzo Stella, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Oncotarget|December 13, 2017
Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjectsLaura F Hutchins, Issam Makhoul, Peter D Emanuel, et al.
Blood Neoplasia|December 22, 2025
Juvenile myelomonocytic leukemia stem cells are sensitive to NK cell-mediated lysis and express targetable antigensShannalee Martinez, Vladimir V Senyukov, Suheyla Hasgur, et al.
Blood|November 15, 1989
Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemiaR J Gualtieri, P D Emanuel, K S Zuckerman, et al.
Blood|December 3, 1998
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemiaA E Frankel, M Lilly, R Kreitman, et al.
Bone Marrow Transplantation|September 1, 1996
Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive diseaseF O Smith, M S Johnson, L R Scherer, et al.
Blood|January 15, 2016
Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancyY Lucy Liu, Yan Yan, Cody Webster, et al.
Experimental Cell Research|July 25, 2003
Inhibition of tumorigenicity by the 5'-untranslated RNA of the human c-myc P0 transcriptScott W Blume, Donald M Miller, Vincenzo Guarcello, et al.
Journal of the American Academy of Dermatology|June 18, 2013
A case of proteasome-associated auto-inflammatory syndrome with compound heterozygous mutationsAmelia McDermott, Adriana Almeida Jesus, Yin Liu, et al.
Journal of Medicinal Chemistry|May 30, 1998
Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemiasD D Muccio, W J Brouillette, T R Breitman, et al.
American Journal of Human Genetics|December 17, 2005
Diversity and functional consequences of germline and somatic PTPN11 mutations in human diseaseMarco Tartaglia, Simone Martinelli, Lorenzo Stella, et al.
Pageof 11